4xdk
From Proteopedia
(Difference between revisions)
												
			
			| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1) in complex with norfluoxetine==  | ==Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1) in complex with norfluoxetine==  | ||
| - | <StructureSection load='4xdk' size='340' side='right' caption='[[4xdk]], [[Resolution|resolution]] 3.60Å' scene=''>  | + | <StructureSection load='4xdk' size='340' side='right'caption='[[4xdk]], [[Resolution|resolution]] 3.60Å' scene=''>  | 
== Structural highlights ==  | == Structural highlights ==  | ||
| - | <table><tr><td colspan='2'>[[4xdk]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XDK OCA]. For a <b>guided tour on the structure components</b> use [  | + | <table><tr><td colspan='2'>[[4xdk]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XDK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4XDK FirstGlance]. <br>  | 
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=405:(3S)-3-PHENYL-3-[4-(TRIFLUOROMETHYL)PHENOXY]PROPAN-1-AMINE'>405</scene>, <scene name='pdbligand=408:(3R)-3-PHENYL-3-[4-(TRIFLUOROMETHYL)PHENOXY]PROPAN-1-AMINE'>408</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=PC1:1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE'>PC1</scene>  | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.6Å</td></tr>  | 
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=405:(3S)-3-PHENYL-3-[4-(TRIFLUOROMETHYL)PHENOXY]PROPAN-1-AMINE'>405</scene>, <scene name='pdbligand=408:(3R)-3-PHENYL-3-[4-(TRIFLUOROMETHYL)PHENOXY]PROPAN-1-AMINE'>408</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=PC1:1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE'>PC1</scene></td></tr>  | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[  | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4xdk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xdk OCA], [https://pdbe.org/4xdk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4xdk RCSB], [https://www.ebi.ac.uk/pdbsum/4xdk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4xdk ProSAT]</span></td></tr>  | 
</table>  | </table>  | ||
== Function ==  | == Function ==  | ||
| - | [  | + | [https://www.uniprot.org/uniprot/KCNKA_HUMAN KCNKA_HUMAN] Outward rectifying potassium channel. Produces rapidly activating and non-inactivating outward rectifier K(+) currents. Activated by arachidonic acid and other naturally occurring unsaturated free fatty acids.  | 
<div style="background-color:#fffaf0;">  | <div style="background-color:#fffaf0;">  | ||
== Publication Abstract from PubMed ==  | == Publication Abstract from PubMed ==  | ||
| Line 21: | Line 21: | ||
==See Also==  | ==See Also==  | ||
| - | *[[Potassium   | + | *[[Potassium channel 3D structures|Potassium channel 3D structures]]  | 
== References ==  | == References ==  | ||
<references/>  | <references/>  | ||
__TOC__  | __TOC__  | ||
</StructureSection>  | </StructureSection>  | ||
| - | [[Category:   | + | [[Category: Homo sapiens]]  | 
| - | [[Category:   | + | [[Category: Large Structures]]  | 
| - | [[Category:   | + | [[Category: Arrowsmith CH]]  | 
| - | [[Category:   | + | [[Category: Bountra C]]  | 
| - | [[Category:   | + | [[Category: Burgess-Brown NA]]  | 
| - | [[Category:   | + | [[Category: Carpenter EP]]  | 
| - | [[Category:   | + | [[Category: Dong YY]]  | 
| - | [[Category:   | + | [[Category: Edwards AM]]  | 
| - | [[Category:   | + | [[Category: Mackenzie A]]  | 
| - | [[Category:   | + | [[Category: Mukhopadhyay S]]  | 
| - | + | [[Category: Pike ACW]]  | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | [[Category:   | + | |
Current revision
Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1) in complex with norfluoxetine
  | |||||||||||
